AMD: First Quarter Analyst Consensus Estimates

Advanced Micro Devices (NASDAQ: AMD) will be reporting their first quarter financial results on April 27th after market close. Analysts have a consensus $102.50 12-month price target on the company, via a total of 39 analysts, with six analysts having strong buy ratings. 18 analysts meanwhile have buy ratings, 13 have hold ratings, 1 analyst has a sell rating and 1 has a strong sell rating on the company. The street high comes from Elazar Advisors with a $161.90 price target, and the lowest target sits at $59 from Clevelland Research.

29 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 29 analysts is $3.22 billion; this number has been revised upwards from $2.73 billion at the start of the year. The highest revenue estimate is $3.3 billion, while the lowest is $3.1 billion.

Onto EBITDA estimates, there are currently only 8 analysts who have first-quarter EBITDA estimates. The mean is currently $718.9 million, with this number having been revised upwards from $519.11 million at the start of the year. The street high estimate currently sits at $739.2 million in EBITDA and the lowest is $651.5 million.

Analysts estimate that quarterly earnings per share will come in at $0.45, with this number being slightly revised upwards from $0.35 at the start of the year. Street high is $0.48 and the lowest estimate is $0.35 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Kinross Gold: Canaccord Lowers Target To $10.50

On February 16th, Kinross Gold Corp (TSX: K) put out a number of news releases,...

Thursday, February 24, 2022, 04:52:00 PM

Canaccord: “We Believe The Fundamentals Of Lundin Mining Remain Strong”

This morning, Cannacord Genuity reiterated their C$11 price target and Buy rating on Lundin Mining...

Friday, October 30, 2020, 01:49:00 PM

Hexo: Canaccord Raises Price Target To $9.50

On March 18th, Hexo Corp (TSX: HEXO) (NYSE: HEXO) reported their fiscal second quarter results....

Sunday, March 21, 2021, 02:29:00 PM

Canaccord Lowers Else Nutrition Estimates After Disappointing Quarter

This past week, Else Nutrition (CSE: BABY) reported their second quarter financial results. The company...

Friday, September 3, 2021, 11:11:00 AM

Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused

On August 3, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Wednesday, September 29, 2021, 11:44:00 AM